In addition, studies have shown that imatinib, as a PDGFRβ inhibitor, can inhibit the differentiation of pericytes into fibroblasts by blocking the PDGF‐BB/PDGFRβ signaling pathway, thus improving pulmonary fibrosis [185]. The gene discussed is PDGFRB; the disease is pulmonary fibrosis.